cardiology11.86 min read
New Multisociety Guideline Uses Five Acute PE Categories to Guide Care
8 days ago•Source: American College of Cardiology
Cardiology News
The latest cardiology stories, summarized by AI
Featured Cardiology Stories
View original source
4.785 min•3 months ago
Emerging Research Challenges Traditional AFib Treatment Approaches
The CLOSURE-AF trial found that left atrial appendage occlusion (LAAO) is not noninferior to standard medical care, including anticoagulants, for high-risk atrial fibrillation patients, with standard care showing better outcomes in stroke and bleeding prevention.
More Top Stories
2
High Prevalence of Recreational Drug Use in Cardiac Intensive Care Patients
Medpage Today•2 years ago
3
Vitamin D Supplements Show Promise in Heart Health
Medpage Today•2 years ago
More Cardiology Stories
COVID-19 positive donor hearts linked to higher mortality in heart transplant patients.
Heart transplant recipients from donors with active COVID-19 infection had higher mortality at 6 months and at 1 year than those with transplants from donors who had either a recently resolved COVID case or did not have COVID, according to a retrospective analysis. However, heart transplants from recently resolved COVID donors had similar post-transplant mortality to non-COVID donors. The study highlights the need for continued evaluation, risk-stratification, and a more nuanced approach in evaluating potential heart donors with COVID-19 infection.
Reconsidering Long-Term Beta-Blocker Use After Heart Attack
Beta-blocker treatment beyond 1 year after myocardial infarction (MI) for patients without heart failure or left ventricular systolic dysfunction was not associated with improved cardiovascular outcomes in a new analysis of a nationwide cohort of more than 40,000 patients. The study was published online in Heart on May 2. The authors suggest that determining whether beta-blockers are indicated beyond the first year after MI may have an impact on patient health-related quality of life. More evidence from large randomized clinical trials is needed to answer this question.
Painkillers and Diabetes: Heart Failure Risk and Treatment Options.
Short-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk for heart failure hospitalization among patients with type 2 diabetes (T2D), according to a Danish registry study. The most at-risk subgroups were patients ages 80 and older, those poorly managed as evidenced by elevated HbA1c levels and no or only one antidiabetic drug, and new NSAID users without previous prescriptions. Several position statements already caution against both short-term and long-term use of NSAIDs in patients at high cardiovascular risk.